{"id":349217,"date":"2025-08-25T16:46:37","date_gmt":"2025-08-25T16:46:37","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-medifast\/"},"modified":"2025-08-25T16:46:37","modified_gmt":"2025-08-25T16:46:37","slug":"how-to-buy-medifast","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/","title":{"rendered":"How to buy Medifast, Inc. (MED) shares &#8211; Investment in Medifast, Inc. (MED) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Medifast, Inc. (MED) Shares - Investment in Medifast, Inc. (MED) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Medifast, Inc. (MED) Shares - Investment in Medifast, Inc. (MED) Stock"},"description":"Learn how to buy Medifast, Inc. (MED) shares with our comprehensive investment guide. Discover current stock price, risk analysis, and step-by-step purchasing instructions for 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Medifast, Inc. (MED) shares with our comprehensive investment guide. Discover current stock price, risk analysis, and step-by-step purchasing instructions for 2025."},"intro":"Thinking about adding a health and wellness stock to your portfolio? Medifast, Inc. (MED) offers an intriguing opportunity despite recent challenges. As the company navigates the disruptive GLP-1 medication revolution, smart investors are watching for turnaround signals. Let's explore whether this stock deserves a place in your investment strategy.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about adding a health and wellness stock to your portfolio? Medifast, Inc. (MED) offers an intriguing opportunity despite recent challenges. As the company navigates the disruptive GLP-1 medication revolution, smart investors are watching for turnaround signals. Let's explore whether this stock deserves a place in your investment strategy."},"body_html":"<h2>\ud83d\udcc8 Medifast Stock: Current Price and Critical Dates<\/h2> <p>As of August 25, 2025, Medifast, Inc. (MED) trades at <strong>$14.29<\/strong> on the NYSE. This price reflects the significant challenges the company has faced throughout 2025, but also presents potential opportunity for contrarian investors.<\/p> <p><strong>Mark Your Calendar: November 3, 2025<\/strong> - This is your next major catalyst date when Medifast releases Q3 2025 earnings. Historically, earnings reports have created substantial price movements for MED stock.<\/p> <p><strong>How Earnings Reports Typically Move MED Stock:<\/strong><\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 4, 2025<\/td><td>Q2 Earnings<\/td><td>$13.75<\/td><td>+3.9% (beat expectations)<\/td><\/tr> <tr><td>May 6, 2025<\/td><td>Q1 Earnings<\/td><td>$16.20<\/td><td>-28.7% (revenue miss)<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Annual Results<\/td><td>$18.50<\/td><td>-12.4% (guidance cut)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Product Launch<\/td><td>$19.80<\/td><td>+5.1% (OPTAVIA ACTIVE)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Q2 Earnings<\/td><td>$21.40<\/td><td>-15.2% (coach decline)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Medifast shares typically experience significant volatility around earnings, with positive surprises creating 3-5% bounces while misses can trigger 15-30% declines. The August 2025 earnings beat provided a modest relief rally despite ongoing fundamental challenges.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2> <p>Medifast shares have declined <strong>approximately 19%<\/strong> over the past six months, reflecting the company's operational challenges:<\/p> <ul> <li><strong>February 2025<\/strong>: ~$17.62 (post-Q4 earnings optimism)<\/li> <li><strong>March 2025<\/strong>: ~$15.80 (GLP-1 competition concerns intensify)<\/li> <li><strong>May 2025<\/strong>: ~$11.50 (Q1 earnings disaster, -28.7% drop)<\/li> <li><strong>July 2025<\/strong>: ~$13.20 (stabilization attempts)<\/li> <li><strong>August 2025<\/strong>: $14.29 (modest recovery after Q2 beat)<\/li> <\/ul> <p><strong>Why the volatility?<\/strong><\/p> <ul> <li>GLP-1 medication revolution disrupting traditional weight loss market<\/li> <li>32.7% decline in active OPTAVIA coaches<\/li> <li>Revenue per coach pressure despite cost-cutting measures<\/li> <li>Market uncertainty about business model sustainability<\/li> <\/ul>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p><strong>Near-Term (Q4 2025)<\/strong>: $13-16 range - The stock likely remains range-bound until clear evidence of coach count stabilization emerges. Current analyst consensus suggests <strong>$16.50<\/strong> as a reasonable 12-month target (<a href=\"https:\/\/stockanalysis.com\/stocks\/med\/forecast\/\">StockAnalysis<\/a>).<\/p> <p><strong>2026 Forecast<\/strong>: $18-22 - If Medifast successfully executes its GLP-1 integration strategy and stabilizes coach numbers, we could see a recovery toward the $20 level.<\/p> <p><strong>2028 Forecast<\/strong>: $25-35 - Successful diversification into sports nutrition ($200B market) and Hispanic market expansion could drive meaningful growth.<\/p> <p><strong>2030 Forecast<\/strong>: $40-60 - Long-term success depends on transforming from a pure weight loss company to a comprehensive health and wellness platform.<\/p> <p><strong>Verdict<\/strong>: <strong>HOLD<\/strong> for existing investors, <strong>SELECTIVE BUY<\/strong> for risk-tolerant investors at current levels. The strong balance sheet ($164.6M cash, no debt) provides downside protection while strategic initiatives offer upside potential.<\/p>  <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>GLP-1 disruption<\/strong>: Traditional weight loss programs losing relevance as medications become mainstream (<a href=\"https:\/\/www.businesswire.com\/news\/home\/20250430945755\/en\/U.S.-Meal-Replacements-Market-Report-2025-with-Competitor-Profiles-for-Medifast-Herbalife-Slim-Fast-Simply-Good-Foods-BeachBody-Visalis-Life-Sciences-Isagenix-Shaklee-Amway-Nu-Skin---ResearchAndMarkets.com\">BusinessWire<\/a>)<\/li> <li><strong>Coach network erosion<\/strong>: 32.7% year-over-year decline in active coaches threatens the core business model<\/li> <li><strong>Revenue pressure<\/strong>: Q3 2025 guidance of $70-90M represents continued sequential decline<\/li> <li><strong>Profitability concerns<\/strong>: Q3 EPS guidance of ($0.60) to breakeven indicates potential losses<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Balance sheet strength<\/strong>: $164.6M cash with zero debt provides operational flexibility<\/li> <li><strong>Cost management<\/strong>: 28.4% SG&A reduction shows disciplined expense control<\/li> <li><strong>Strategic pivots<\/strong>: GLP-1 integration and sports nutrition expansion address market changes<\/li> <li><strong>Margin maintenance<\/strong>: 72.8% gross margins remain industry-leading despite revenue pressure<\/li> <li><strong>Analyst support<\/strong>: Despite challenges, Wall Street maintains $16.50 price target (+15% upside)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Allocate no more than 2-3% of your portfolio to MED given the high risk profile<\/li> <li><strong>Dollar-cost average<\/strong> - Consider buying in increments rather than one large position<\/li> <li><strong>Set stop-losses<\/strong> - Protect your capital with stops around $13.00 level<\/li> <li><strong>Monitor coach metrics<\/strong> - The single most important indicator is quarterly active coach numbers<\/li> <li><strong>Humorous take<\/strong>: \"Trading MED is like dieting - sometimes you need to accept temporary setbacks for long-term gains. Just don't let your portfolio go on one of those crash diets!\"<\/li> <\/ol>  <h2>\u2705 How to Buy Medifast, Inc. (MED) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a brokerage platform<\/td><td>Ensure it offers NYSE access and low commissions<\/td><\/tr> <tr><td>2<\/td><td>Open and fund your account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Research MED thoroughly<\/td><td>Understand the GLP-1 disruption risks<\/td><\/tr> <tr><td>4<\/td><td>Use limit orders<\/td><td>Set your maximum purchase price to avoid overpaying<\/td><\/tr> <tr><td>5<\/td><td>Monitor position size<\/td><td>Keep MED allocation appropriate for your risk tolerance<\/td><\/tr> <tr><td>6<\/td><td>Set price alerts<\/td><td>Get notified of major price movements<\/td><\/tr> <tr><td>7<\/td><td>Review quarterly reports<\/td><td>Pay special attention to coach numbers and guidance<\/td><\/tr> <tr><td>8<\/td><td>Consider tax implications<\/td><td>Understand holding period requirements for favorable treatment<\/td><\/tr> <tr><td>9<\/td><td>Diversify appropriately<\/td><td>MED should be part of a balanced portfolio<\/td><\/tr> <tr><td>10<\/td><td>Have an exit strategy<\/td><td>Know your profit targets and stop-loss levels in advance<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those considering Medifast exposure, Pocket Option offers several advantages for beginners:<\/p> <ul> <li><strong>Minimum deposit: $5<\/strong> - Test strategies with minimal risk while learning the markets<\/li> <li><strong>Quick verification<\/strong> - Start trading within minutes with streamlined KYC process<\/li> <li><strong>Fractional shares<\/strong> - Buy portions of MED stock without needing full share amounts<\/li> <li><strong>Educational resources<\/strong> - Access learning materials to understand healthcare sector investing<\/li> <li><strong>Mobile accessibility<\/strong> - Monitor your MED position from anywhere with their intuitive app<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for investors who want to establish a small position in Medifast while maintaining proper risk management.<\/p>  <h2>\ud83c\udf0d Medifast in 2025: Navigating Industry Transformation<\/h2> <p>Medifast operates in the challenging weight loss and wellness sector, primarily through its OPTAVIA\u00ae coach-guided program. The company faces unprecedented disruption from GLP-1 medications like Ozempic and Wegovy, which have caused a <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250430945755\/en\/U.S.-Meal-Replacements-Market-Report-2025-with-Competitor-Profiles-for-Medifast-Herbalife-Slim-Fast-Simply-Good-Foods-BeachBody-Visalis-Life-Sciences-Isagenix-Shaklee-Amway-Nu-Skin---ResearchAndMarkets.com\">$1.5 billion revenue loss<\/a> across meal replacement companies, with Medifast being disproportionately affected.<\/p> <p><strong>Current Business Focus:<\/strong><\/p> <ul> <li>Integrating with GLP-1 medications rather than competing against them<\/li> <li>Expanding into sports nutrition through OPTAVIA ACTIVE<\/li> <li>Targeting Hispanic market demographics<\/li> <li>Maintaining industry-leading 72.8% gross margins through cost discipline<\/li> <\/ul> <p><strong>Interesting Fact for 2025<\/strong>: Despite the challenging environment, Medifast's cash position of $164.6 million represents approximately 115% of its current market capitalization - meaning the market is valuing the ongoing business at virtually zero despite its strategic repositioning efforts.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Medifast Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 25, 2025, Medifast, Inc. (MED) trades at <strong>$14.29<\/strong> on the NYSE. This price reflects the significant challenges the company has faced throughout 2025, but also presents potential opportunity for contrarian investors.<\/p>\n<p><strong>Mark Your Calendar: November 3, 2025<\/strong> &#8211; This is your next major catalyst date when Medifast releases Q3 2025 earnings. Historically, earnings reports have created substantial price movements for MED stock.<\/p>\n<p><strong>How Earnings Reports Typically Move MED Stock:<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 4, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$13.75<\/td>\n<td>+3.9% (beat expectations)<\/td>\n<\/tr>\n<tr>\n<td>May 6, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$16.20<\/td>\n<td>-28.7% (revenue miss)<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Annual Results<\/td>\n<td>$18.50<\/td>\n<td>-12.4% (guidance cut)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Product Launch<\/td>\n<td>$19.80<\/td>\n<td>+5.1% (OPTAVIA ACTIVE)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>$21.40<\/td>\n<td>-15.2% (coach decline)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Medifast shares typically experience significant volatility around earnings, with positive surprises creating 3-5% bounces while misses can trigger 15-30% declines. The August 2025 earnings beat provided a modest relief rally despite ongoing fundamental challenges.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2>\n<p>Medifast shares have declined <strong>approximately 19%<\/strong> over the past six months, reflecting the company&#8217;s operational challenges:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: ~$17.62 (post-Q4 earnings optimism)<\/li>\n<li><strong>March 2025<\/strong>: ~$15.80 (GLP-1 competition concerns intensify)<\/li>\n<li><strong>May 2025<\/strong>: ~$11.50 (Q1 earnings disaster, -28.7% drop)<\/li>\n<li><strong>July 2025<\/strong>: ~$13.20 (stabilization attempts)<\/li>\n<li><strong>August 2025<\/strong>: $14.29 (modest recovery after Q2 beat)<\/li>\n<\/ul>\n<p><strong>Why the volatility?<\/strong><\/p>\n<ul>\n<li>GLP-1 medication revolution disrupting traditional weight loss market<\/li>\n<li>32.7% decline in active OPTAVIA coaches<\/li>\n<li>Revenue per coach pressure despite cost-cutting measures<\/li>\n<li>Market uncertainty about business model sustainability<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p><strong>Near-Term (Q4 2025)<\/strong>: $13-16 range &#8211; The stock likely remains range-bound until clear evidence of coach count stabilization emerges. Current analyst consensus suggests <strong>$16.50<\/strong> as a reasonable 12-month target (<a href=\"https:\/\/stockanalysis.com\/stocks\/med\/forecast\/\">StockAnalysis<\/a>).<\/p>\n<p><strong>2026 Forecast<\/strong>: $18-22 &#8211; If Medifast successfully executes its GLP-1 integration strategy and stabilizes coach numbers, we could see a recovery toward the $20 level.<\/p>\n<p><strong>2028 Forecast<\/strong>: $25-35 &#8211; Successful diversification into sports nutrition ($200B market) and Hispanic market expansion could drive meaningful growth.<\/p>\n<p><strong>2030 Forecast<\/strong>: $40-60 &#8211; Long-term success depends on transforming from a pure weight loss company to a comprehensive health and wellness platform.<\/p>\n<p><strong>Verdict<\/strong>: <strong>HOLD<\/strong> for existing investors, <strong>SELECTIVE BUY<\/strong> for risk-tolerant investors at current levels. The strong balance sheet ($164.6M cash, no debt) provides downside protection while strategic initiatives offer upside potential.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>GLP-1 disruption<\/strong>: Traditional weight loss programs losing relevance as medications become mainstream (<a href=\"https:\/\/www.businesswire.com\/news\/home\/20250430945755\/en\/U.S.-Meal-Replacements-Market-Report-2025-with-Competitor-Profiles-for-Medifast-Herbalife-Slim-Fast-Simply-Good-Foods-BeachBody-Visalis-Life-Sciences-Isagenix-Shaklee-Amway-Nu-Skin---ResearchAndMarkets.com\">BusinessWire<\/a>)<\/li>\n<li><strong>Coach network erosion<\/strong>: 32.7% year-over-year decline in active coaches threatens the core business model<\/li>\n<li><strong>Revenue pressure<\/strong>: Q3 2025 guidance of $70-90M represents continued sequential decline<\/li>\n<li><strong>Profitability concerns<\/strong>: Q3 EPS guidance of ($0.60) to breakeven indicates potential losses<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Balance sheet strength<\/strong>: $164.6M cash with zero debt provides operational flexibility<\/li>\n<li><strong>Cost management<\/strong>: 28.4% SG&#038;A reduction shows disciplined expense control<\/li>\n<li><strong>Strategic pivots<\/strong>: GLP-1 integration and sports nutrition expansion address market changes<\/li>\n<li><strong>Margin maintenance<\/strong>: 72.8% gross margins remain industry-leading despite revenue pressure<\/li>\n<li><strong>Analyst support<\/strong>: Despite challenges, Wall Street maintains $16.50 price target (+15% upside)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate no more than 2-3% of your portfolio to MED given the high risk profile<\/li>\n<li><strong>Dollar-cost average<\/strong> &#8211; Consider buying in increments rather than one large position<\/li>\n<li><strong>Set stop-losses<\/strong> &#8211; Protect your capital with stops around $13.00 level<\/li>\n<li><strong>Monitor coach metrics<\/strong> &#8211; The single most important indicator is quarterly active coach numbers<\/li>\n<li><strong>Humorous take<\/strong>: &#8220;Trading MED is like dieting &#8211; sometimes you need to accept temporary setbacks for long-term gains. Just don&#8217;t let your portfolio go on one of those crash diets!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 How to Buy Medifast, Inc. (MED) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a brokerage platform<\/td>\n<td>Ensure it offers NYSE access and low commissions<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research MED thoroughly<\/td>\n<td>Understand the GLP-1 disruption risks<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Use limit orders<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor position size<\/td>\n<td>Keep MED allocation appropriate for your risk tolerance<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set price alerts<\/td>\n<td>Get notified of major price movements<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Review quarterly reports<\/td>\n<td>Pay special attention to coach numbers and guidance<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Consider tax implications<\/td>\n<td>Understand holding period requirements for favorable treatment<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Diversify appropriately<\/td>\n<td>MED should be part of a balanced portfolio<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Have an exit strategy<\/td>\n<td>Know your profit targets and stop-loss levels in advance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those considering Medifast exposure, Pocket Option offers several advantages for beginners:<\/p>\n<ul>\n<li><strong>Minimum deposit: $5<\/strong> &#8211; Test strategies with minimal risk while learning the markets<\/li>\n<li><strong>Quick verification<\/strong> &#8211; Start trading within minutes with streamlined KYC process<\/li>\n<li><strong>Fractional shares<\/strong> &#8211; Buy portions of MED stock without needing full share amounts<\/li>\n<li><strong>Educational resources<\/strong> &#8211; Access learning materials to understand healthcare sector investing<\/li>\n<li><strong>Mobile accessibility<\/strong> &#8211; Monitor your MED position from anywhere with their intuitive app<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for investors who want to establish a small position in Medifast while maintaining proper risk management.<\/p>\n<h2>\ud83c\udf0d Medifast in 2025: Navigating Industry Transformation<\/h2>\n<p>Medifast operates in the challenging weight loss and wellness sector, primarily through its OPTAVIA\u00ae coach-guided program. The company faces unprecedented disruption from GLP-1 medications like Ozempic and Wegovy, which have caused a <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250430945755\/en\/U.S.-Meal-Replacements-Market-Report-2025-with-Competitor-Profiles-for-Medifast-Herbalife-Slim-Fast-Simply-Good-Foods-BeachBody-Visalis-Life-Sciences-Isagenix-Shaklee-Amway-Nu-Skin---ResearchAndMarkets.com\">$1.5 billion revenue loss<\/a> across meal replacement companies, with Medifast being disproportionately affected.<\/p>\n<p><strong>Current Business Focus:<\/strong><\/p>\n<ul>\n<li>Integrating with GLP-1 medications rather than competing against them<\/li>\n<li>Expanding into sports nutrition through OPTAVIA ACTIVE<\/li>\n<li>Targeting Hispanic market demographics<\/li>\n<li>Maintaining industry-leading 72.8% gross margins through cost discipline<\/li>\n<\/ul>\n<p><strong>Interesting Fact for 2025<\/strong>: Despite the challenging environment, Medifast&#8217;s cash position of $164.6 million represents approximately 115% of its current market capitalization &#8211; meaning the market is valuing the ongoing business at virtually zero despite its strategic repositioning efforts.<\/p>\n"},"faq":[{"question":"Is now a good time to buy Medifast stock?","answer":"Current prices may represent a potential entry point for risk-tolerant investors, but caution is warranted due to ongoing business model challenges. The strong balance sheet provides downside protection."},{"question":"What's the biggest risk with investing in MED?","answer":"The rapid adoption of GLP-1 medications that are disrupting traditional weight loss approaches. If Medifast cannot successfully adapt its model, continued revenue declines are likely."},{"question":"How often does Medifast pay dividends?","answer":"Medifast does not currently pay dividends and has not indicated plans to initiate a dividend program in the near future."},{"question":"What metrics should I watch most closely?","answer":"Active OPTAVIA coach numbers are the most important indicator, followed by revenue per coach and progress on GLP-1 integration initiatives."},{"question":"How does Medifast's valuation compare to competitors?","answer":"MED trades at significant discounts to historical valuations and some peers due to current challenges, but this may be justified given the fundamental headwinds facing the business model."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy Medifast stock?","answer":"Current prices may represent a potential entry point for risk-tolerant investors, but caution is warranted due to ongoing business model challenges. The strong balance sheet provides downside protection."},{"question":"What's the biggest risk with investing in MED?","answer":"The rapid adoption of GLP-1 medications that are disrupting traditional weight loss approaches. If Medifast cannot successfully adapt its model, continued revenue declines are likely."},{"question":"How often does Medifast pay dividends?","answer":"Medifast does not currently pay dividends and has not indicated plans to initiate a dividend program in the near future."},{"question":"What metrics should I watch most closely?","answer":"Active OPTAVIA coach numbers are the most important indicator, followed by revenue per coach and progress on GLP-1 integration initiatives."},{"question":"How does Medifast's valuation compare to competitors?","answer":"MED trades at significant discounts to historical valuations and some peers due to current challenges, but this may be justified given the fundamental headwinds facing the business model."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:46:37+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Medifast, Inc. (MED) shares &#8211; Investment in Medifast, Inc. (MED) stock\",\"datePublished\":\"2025-08-25T16:46:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\",\"name\":\"How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-25T16:46:37+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Medifast, Inc. (MED) shares &#8211; Investment in Medifast, Inc. (MED) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:46:37+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Medifast, Inc. (MED) shares &#8211; Investment in Medifast, Inc. (MED) stock","datePublished":"2025-08-25T16:46:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/","name":"How to buy Medifast, Inc. (MED) shares - Investment in Medifast, Inc. (MED) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-25T16:46:37+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-medifast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Medifast, Inc. (MED) shares &#8211; Investment in Medifast, Inc. (MED) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":349298,"slug":"how-to-buy-medifast","post_title":"Comment acheter des actions Medifast, Inc. (MED) - Investir dans les actions Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-medifast\/"},"it_IT":{"locale":"it_IT","id":349294,"slug":"how-to-buy-medifast","post_title":"Come acquistare azioni Medifast, Inc. (MED) - Investire in azioni Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-medifast\/"},"pl_PL":{"locale":"pl_PL","id":349296,"slug":"how-to-buy-medifast","post_title":"Jak kupi\u0107 akcje Medifast, Inc. (MED) - Inwestycja w akcje Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-medifast\/"},"es_ES":{"locale":"es_ES","id":349295,"slug":"how-to-buy-medifast","post_title":"C\u00f3mo comprar acciones de Medifast, Inc. (MED) - Inversi\u00f3n en acciones de Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-medifast\/"},"th_TH":{"locale":"th_TH","id":349299,"slug":"how-to-buy-medifast","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Medifast, Inc. (MED) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-medifast\/"},"tr_TR":{"locale":"tr_TR","id":349301,"slug":"how-to-buy-medifast","post_title":"Medifast, Inc. (MED) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medifast, Inc. (MED) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medifast\/"},"vt_VT":{"locale":"vt_VT","id":349300,"slug":"how-to-buy-medifast","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Medifast, Inc. (MED) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-medifast\/"},"pt_AA":{"locale":"pt_AA","id":349297,"slug":"how-to-buy-medifast","post_title":"Como comprar a\u00e7\u00f5es da Medifast, Inc. (MED) - Investimento em a\u00e7\u00f5es da Medifast, Inc. (MED)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-medifast\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/349217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=349217"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/349217\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=349217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=349217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=349217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}